{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:01:44Z","timestamp":1762002104116,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012324","name":"University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012324","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Applied Sciences"},{"name":"University of Applied Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ymgmr.2019.100491","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T19:59:18Z","timestamp":1561751958000},"page":"100491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ketone body therapy with D\/L-\u03b2-hydroxybutyric acid solution in severe MADD"],"prefix":"10.1016","volume":"20","author":[{"given":"Tobias","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Elpers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Och","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Fobker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ymgmr.2019.100491_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2006.01.009","article-title":"Electron transfer flavoprotein deficiency: functional and molecular aspects","volume":"88","author":"Schiff","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100491_bb0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0009-8981(76)90060-7","article-title":"Glutaric aciduria type II: report on a previously undescribed metabolic disorder","volume":"66","author":"Przyrembel","year":"1976","journal-title":"Clin. Chim. Acta"},{"issue":"13","key":"10.1016\/j.ymgmr.2019.100491_bb0015","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1073\/pnas.82.13.4517","article-title":"Deficiency of electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts","volume":"82","author":"Frerman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2019.100491_bb0020","series-title":"The Metabolic & Molecular Bases of Inherited Disease","article-title":"Defects of electron transfer flavoprotein and electron transfer flavoprotein-ubiquinone oxidoreductase: glutaric acidemia type II","author":"Frerman","year":"2004"},{"issue":"S1","key":"10.1016\/j.ymgmr.2019.100491_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03047371","article-title":"Glutaric acidaemia type II (multiple Acyl-Coa dehydrogenation deficiency)","volume":"7","author":"Goodman","year":"1984","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100491_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.jp.7200325","article-title":"Glutaric aciduria type II: observations in seven patients with neonatal- and late-onset disease","volume":"20","author":"al-Essa","year":"2000","journal-title":"J Perinatol: official journal of the California Perinatal Association"},{"issue":"4","key":"10.1016\/j.ymgmr.2019.100491_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0887-8994(95)00187-5","article-title":"Riboflavin-responsive glutaric aciduria type II presenting as a leukodystrophy","volume":"13","author":"Uziel","year":"1995","journal-title":"Pediatr. Neurol."},{"issue":"9367","key":"10.1016\/j.ymgmr.2019.100491_bb0040","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(03)13105-4","article-title":"D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)","volume":"361","author":"van Hove","year":"2003","journal-title":"Lancet"},{"issue":"1\u20131","key":"10.1016\/j.ymgmr.2019.100491_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/pr.2014.154","article-title":"Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy","volume":"77","author":"Gautschi","year":"2015","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.ymgmr.2019.100491_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.2013-4254","article-title":"Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD","volume":"134","author":"van Rijt","year":"2014","journal-title":"Pediatrics"},{"issue":"S1","key":"10.1016\/j.ymgmr.2019.100491_bb0055","first-page":"1","article-title":"O-50: 3-hydroxybutyrate (3-HB) treatment in MADD: a systematic literature review and international retrospective cohort study","volume":"41","author":"van Rijt","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2019.100491_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nut.2018.10.014","article-title":"Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: a case report","volume":"60","author":"Fischer","year":"2019","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100491_bb0065","first-page":"301","article-title":"Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy","volume":"52","author":"Plecko","year":"2002","journal-title":"Pediatr. Res."},{"issue":"58","key":"10.1016\/j.ymgmr.2019.100491_bb0070","first-page":"53","article-title":"Ketone bodies as a possible adjuvant to ketogenic diet in PDHc deficiency but not in GLUT1 deficiency","author":"Habarou","year":"2017","journal-title":"JIMD Rep."},{"issue":"12","key":"10.1016\/j.ymgmr.2019.100491_bb0075","first-page":"204","article-title":"Dietary supplements based on the ketone body \u03b2-hydroxybutyrate: market analysis and evaluation of ingredients of supplements used in the USA","volume":"65","author":"Fischer","year":"2018","journal-title":"Ern\u00e4hrungs-Umschau"},{"key":"10.1016\/j.ymgmr.2019.100491_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fphys.2017.00848","article-title":"On the metabolism of exogenous ketones in humans","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.ymgmr.2019.100491_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI111408","article-title":"Effect of ketone bodies on glucose production and utilization in the miniature pig","volume":"74","author":"M\u00fcller","year":"1984","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100491_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1210\/jcem-67-2-245","article-title":"Effect of exercise on the disposal of infused ketone bodies in humans","volume":"67","author":"F\u00e9ry","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgmr.2019.100491_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9812806","article-title":"Effect of a sodium and calcium DL-\u03b2-Hydroxybutyrate salt in healthy adults","volume":"2018","author":"Fischer","year":"2018","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.ymgmr.2019.100491_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00806","article-title":"Ketone diester ingestion impairs time-trial performance in professional cyclists","volume":"8","author":"Leckey","year":"2017","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.ymgmr.2019.100491_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","article-title":"Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects","volume":"63","author":"Clarke","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ymgmr.2019.100491_bb0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/17461391.2017.1421711","article-title":"Effect of acute ingestion of \u03b2-hydroxybutyrate salts on the response to graded exercise in trained cyclists","volume":"18","author":"Evans","year":"2018","journal-title":"Eur. J. Sport Sci."},{"issue":"4","key":"10.1016\/j.ymgmr.2019.100491_bb0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.adaj.2015.10.019","article-title":"The pH of beverages in the United States","volume":"147","author":"Reddy","year":"1939","journal-title":"J. Am. Dent. Assoc."},{"issue":"1","key":"10.1016\/j.ymgmr.2019.100491_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000016499","article-title":"Enamel erosion by some soft drinks and orange juices relative to their pH, buffering effect and contents of calcium phosphate","volume":"33","author":"Larsen","year":"1999","journal-title":"Caries Res."},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100491_bb0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/adj.12498","article-title":"Food acid content and erosive potential of sugar-free confections","volume":"62","author":"Shen","year":"2017","journal-title":"Aust. Dent. J."},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100491_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MOG.0000000000000337","article-title":"Diet and gastroesophageal reflux disease: role in pathogenesis and management","volume":"33","author":"Sethi","year":"2017","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ymgmr.2019.100491_bb0135","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00424-007-0247-x","article-title":"Signal transduction and information processing in mammalian taste buds","volume":"454","author":"Roper","year":"2007","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100491_bb0140","first-page":"R33","article-title":"The chemistry and physiology of sour taste\u2014a review","volume":"72","author":"Ramos Da Conceicao Neta","year":"2007","journal-title":"J. Food Sci."},{"issue":"7","key":"10.1016\/j.ymgmr.2019.100491_bb0145","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jada.2007.04.007","article-title":"Food oxalate: factors affecting measurement, biological variation, and bioavailability","volume":"107","author":"Massey","year":"2007","journal-title":"J. Am. Diet. Assoc."},{"issue":"3","key":"10.1016\/j.ymgmr.2019.100491_bb0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.urology.2014.03.053","article-title":"Oxalate content of food: a tangled web","volume":"84","author":"Attalla","year":"2014","journal-title":"Urology"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221442691930076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221442691930076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:04Z","timestamp":1762001464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221442691930076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":30,"alternative-id":["S221442691930076X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2019.100491","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketone body therapy with D\/L-\u03b2-hydroxybutyric acid solution in severe MADD","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2019.100491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100491"}}